Since 1994, Pappas Ventures has been nurturing promising life sciences ideas and delivering superior results to investors and entrepreneurs alike.
Portfolio Highlights
Pappas Ventures News
-
Venture-Backed Biotech's 2011 M&A Exits Outpaced Both Investments and Fundraising
January 16, 2012 -
A look back, and forward - Plexxikon
December 23, 2011
In the Spotlight
-
Barry Myers, MD, PhD, Executive-in-Residence
In addition to serving as Executive-in-Residence since 2004, Barry is also the Director of Emerging Programs at the Duke Translational Research Institute and professor of biomedical engineering at Duke University.
-
Syndax Pharmaceuticals
The recently announced phase 2 results show median survival advantage of seven months for exemestane plus entinostat treated women with advanced breast cancer.